semaglutide death rate Postpartum prescription of #GLP-1RAs in Denmark increased between 2018 and 2024, with #semaglutide accounting for most prescriptions since 2023. Most users had #overweight or #obesity, and only 23% had a #diabetes diagnosis FLOWing with the SemagluTIDE —

But combining it with positive lifestyle changes produces the most impactful results

Averages Hide a Wide Distribution STEP 1 reported responder rates alongside the mean, and they are the more useful statistic for an individual

As evidence accumulates, underwriting approaches must evolve to recognize improvements while maintaining vigilance to validate these therapies potential

GLP-1RA or dual GIP/GLP-1RA added to basal insulin compared to basal insulin titrated with a rigorous intention-to-treat approach is moderately effective in preventing further increase in daily basal insulin dose from achieving treat-to-target glycemic goals ( daily insulin dose, SMD -0.49, 95% CI -0.71